Role of Continuous High Thoracic Epidural Anesthesia in Hippocampal Apoptosis after Global Cerebral Ischemia in Rats

Role of Continuous High Thoracic Epidural Anesthesia in Hippocampal Apoptosis after Global Cerebral Ischemia in Rats

Background: Cervical sympathetic blockade has been found to reduce cerebral vascular resistance and improve focal cerebral ischemia/reperfusion injury. In this study, we tested the hypothesis that the sympathetic blockade of high thoracic epidural anesthesia (HTEA) would reduce hippocampal apoptosis...

Full description

Bibliographic Details
Main Authors:	Xuan Li, Xing Huo, Chongyou Zhang, Xinyu Ma, Fei Han, Guonian Wang
Format:	Article
Language:	English
Published:	Cell Physiol Biochem Press GmbH & Co KG 2014-09-01
Series:	Cellular Physiology and Biochemistry
Subjects:	High thoracic epidural anesthesia (HTEA) Cerebral ischemia Global Rats Apoptosis Poly (ADP-ribose) polymerase (PARP)
Online Access:	http://www.karger.com/Article/FullText/366334

Similar Items

Poly(ADP-Ribose) Glycohydrolase (PARG) vs. Poly(ADP-Ribose) Polymerase (PARP) – Function in Genome Maintenance and Relevance of Inhibitors for Anti-cancer Therapy
by: Daniel Harrision, et al.
Published: (2020-08-01)

Nanoparticle Formulations of Poly (ADP-ribose) Polymerase Inhibitors for Cancer Therapy
by: Bijay Singh, et al.
Published: (2020-11-01)

Approches protéomiques appliquées à l'étude de la poly(adp-ribosyl)ation
by: Gagné, Jean-Philippe
Published: (2009)

Polyclonal BRCA2 mutations following carboplatin treatment confer resistance to the PARP inhibitor rucaparib in a patient with mCRPC: a case report
by: Andrew D. Simmons, et al.
Published: (2020-03-01)

Discovery of 2-(1-(3-(4-Chloroxyphenyl)-3-oxo- propyl)pyrrolidine-3-yl)-1<i>H</i>-benzo[d]imidazole-4-carboxamide: A Potent Poly(ADP-ribose) Polymerase (PARP) Inhibitor for Treatment of Cancer
by: Rui Min, et al.
Published: (2019-05-01)

Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol
by: Paul Lesueur, et al.
Published: (2019-03-01)

Potentiel des inhibiteurs de poly(ADP-ribose) polymérases seuls ou en combinaison avec la radiothérapie comme nouvelle option thérapeutique pour le carcinome hépatocellulaire
by: Guillot, Clément
Published: (2013)

Strategies for structural studies of poly(ADP-ribose) glycohydrolase: Towards the validation of a novel therapeutic target
by: Botta, Davide
Published: (2010)

Effect of Partial Poly (ADP-ribose) Glycohydrolase Gene Deletion on Cellular Responses to Genotoxic Stress
by: Gao, Hong
Published: (2006)

A Review on DNA Repair Inhibition by PARP Inhibitors in Cancer Therapy
by: Shah Ashish P., et al.
Published: (2018-03-01)

Structural implications for selective targeting of PARPs
by: Jamin D. Steffen, et al.
Published: (2013-12-01)

Poly (ADP-Ribose) Polymerase Inhibitor Treatment as a Novel Therapy Attenuating Renal Ischemia-Reperfusion Injury
by: Hye Ryoun Jang, et al.
Published: (2020-10-01)

Analyses biochimique et protéomique de la poly(ADP-ribosyl)ation
by: Tardif, Maxime
Published: (2011)

Automodified Poly(ADP-Ribose) Polymerase Analysisto Monitor DNA Damagein Peripheral Lymphocytes of Floriculturists Occupationally Exposed to Pesticides
by: Serena Imperato, et al.
Published: (2019-02-01)

Studies of the metal binding properties and DNA recognition mode of the unusual zinc fingers in poly(ADP-ribose) Polymerase-1 and the investigation of its interaction with apoptosis inducing factor (AIF)
by: Zhou, Ying, 1977-
Published: (2013)

Abstract P-16: Interaction of Poly(ADP-Ribose)Polymerase1 and Poly(ADP-Ribose)Polymerase2 with Nucleosome during Base Excision Repair
by: Mikhail M. Kutuzov, et al.
Published: (2019-06-01)

Characterization of TCDD-inducible poly-ADP-ribose polymerase (TIPARP/ARTD14) catalytic activity
by: Gomez, A., et al.
Published: (2021)

PARP inhibitors: review of mechanisms of action and BRCA1/2 mutation targeting
by: Karolina N. Dziadkowiec, et al.
Published: (2017-02-01)

PARP Inhibitors: An Innovative Approach to the Treatment of Inflammation and Metabolic Disorders in Sepsis
by: Wasyluk W, et al.
Published: (2021-05-01)

Interactome des intervenants dans le métbolisme du poly(ADP-ribose)
by: Isabelle, Maxim
Published: (2012)

Reduced Tumorigenicity of Mouse ES Cells and the Augmented Anti-Tumor Therapeutic Effects under <i>Parg</i> Deficiency
by: Yuki Sonoda, et al.
Published: (2020-04-01)

Editorial: Inhibiting PARP as a Strategic Target in Cancer
by: Kristin eZorn, et al.
Published: (2016-04-01)

In Vivo Level of Poly(ADP-ribose)
by: Masanao Miwa, et al.
Published: (2018-05-01)

Molecular Insights into Poly(ADP-ribose) Recognition and Processing
by: Ivan Ahel, et al.
Published: (2012-12-01)

PARP Traps Rescue the Pro-Inflammatory Response of Human Macrophages in the In Vitro Model of LPS-Induced Tolerance
by: Julita Pietrzak, et al.
Published: (2021-02-01)

The Role of PARP1 in Monocyte and Macrophage Commitment and Specification: Future Perspectives and Limitations for the Treatment of Monocyte and Macrophage Relevant Diseases with PARP Inhibitors
by: Maciej Sobczak, et al.
Published: (2020-09-01)

PARP7 and Mono-ADP-Ribosylation Negatively Regulate Estrogen Receptor α Signaling in Human Breast Cancer Cells
by: Marit Rasmussen, et al.
Published: (2021-03-01)

Inhibiting poly(ADP-ribosylation) improves axon regeneration
by: Alexandra B Byrne, et al.
Published: (2016-10-01)

Rôle de la poly(ADP-ribose)polymérase dans l'activation et l'agrégation plaquettaires à la suite d'une ischémie cérébrale
by: Lechaftois, Marie
Published: (2013)

Resistance to PARP-inhibitors in Cancer Therapy
by: Alicia eMontoni, et al.
Published: (2013-02-01)

Rôle de la poly (ADP-ribose) polymérase-1 (PARP-1)dans la réparation de l'ADN par excision de nucléotides
by: Robu, Mihaela
Published: (2010)

Proteomique fonctionnelle des poly(ADP-Ribose) polymerases
by: Moreel, Xavier
Published: (2010)

Poly(ADP-ribose) polymerase-1 : domain C structure, poly(ADP-ribosyl)ation sites and physiological functions
by: Tao, Zhihua, 1977-
Published: (2012)

Sevoflurane and thoracic epidural anesthesia for trans-sternal thymectomy in a child with juvenile myasthenia gravis
by: Valluvan Rangasamy, et al.
Published: (2014-01-01)

Structurally unique PARP‐1 inhibitors for the treatment of prostate cancer
by: Ali Divan, et al.
Published: (2020-04-01)

Fused in Sarcoma (FUS) in DNA Repair: Tango with Poly(ADP-ribose) Polymerase 1 and Compartmentalisation of Damaged DNA
by: Maria V. Sukhanova, et al.
Published: (2020-09-01)

Toward a Quantitative Analysis of PARP-1 and Poly(ADP-ribosyl)ation in Cellular Senescence
by: Edmonds, Yvette M.
Published: (2014)

Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy
by: Stephen A. Jannetti, et al.
Published: (2020-03-01)

Poly(ADP-Ribose) Polymerases in Plants and Their Human Counterparts: Parallels and Peculiarities
by: Dagmar Rissel, et al.
Published: (2019-04-01)

Measurement of Poly(ADP-ribose) Level with Enhanced Slot Blot Assay with Crosslinking
by: Yuko Kudo, et al.
Published: (2018-07-01)